ADIPOQ and neoplasm: This finding indicates that angiogenic factors produced by visceral fat may influence tumor progression and response to chemotherapy and is mirrored in animal models as adiponectin, which is reduced in visceral obesity, inhibits tumor growth by reduced neovascularisation[72].